Medco/Merck Contract Gets New Spin; Renegotiation May Avert Zocor Impact

Medco's renegotiation of its rebate agreement with Merck may have allowed the pharmacy benefit manager to avoid loss of rebates accompanying Zocor'slooming patent expiration